United Therapeutics Corp (UTHR) — Analysis Summary
United Therapeutics Corp (UTHR) has a market cap of $23.64B with year-over-year revenue growth of +10.6%. Net margin stands at 41.9%. The stock trades at a P/E ratio of 18.4.
Key Takeaways
- Revenue changed +10.6% year-over-year
- Net margin of 41.9%
- P/E ratio of 18.4
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, UTHR posted revenue growth of +10.6% and trades at a P/E of 18.4.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.